While L’Oréal continues to post impressive financial results, market analysts at JP Morgan are maintaining a cautious stance. The firm has reaffirmed its neutral rating on the cosmetics giant, holding steady with a price target of €360. According to Celine Pannuti, an analyst at the bank, the current share price already fully reflects the company’s valuation. This perspective arrives amidst a challenging period for the European consumer goods sector, where numerous companies have recently fallen short of quarterly sales expectations. JP Morgan’s broader outlook suggests that global market growth is likely to remain below historical averages, even with anticipated modest demand recovery in key regions like China and the United States.
Robust Interim Results Provide Counterpoint
The context for this analyst skepticism is L’Oréal’s solid first-half performance for the period ending June 30, 2025. The company announced total sales of €22.47 billion, achieving a like-for-like growth rate of +3.0%. A notable acceleration was observed, with growth climbing from +2.6% in the first quarter to +3.7% in the second. Profitability also reached new heights, with the operating margin hitting a record 21.1%, representing an increase of 30 basis points. Every single division surpassed an operating margin of 22%.
On the bottom line, the adjusted net profit rose by +1.0% to approximately €3.8 billion. It is important to note, however, that the reported net profit saw a decline of -7.8% to €3.37 billion, a drop primarily attributed to a special corporate tax levied on large companies in France.
Key highlights from the half-year report include:
Should investors sell immediately? Or is it worth buying L'Oréal?
- Geographic Performance: Emerging markets delivered double-digit growth, while Mainland China returned to positive growth territory.
- Division-Wide Strength: All business divisions expanded, led by the Professional Products segment.
- Category Leaders: The fragrance and hair care categories remained the fastest-growing segments.
- Strategic Expansion: Recent acquisitions, including Medik8 and Color Wow, have served to strengthen the overall brand portfolio.
Trading Activity and Technical Indicators Show Mixed Signals
The stock’s recent trading pattern reflects ongoing market volatility. Shares gained 0.274% in the previous session, closing at €402.35. Today’s trading opened at €404.13, with an anticipated range between €398.70 and €406.00, suggesting potential intraday movements of roughly 1.83%. Despite this upward price movement, trading volume decreased on the last trading day, a detail some observers view as a potential early indicator of a future trend reversal.
From a technical analysis standpoint, the equity is emitting several positive buy signals. Short-term moving averages are positioned above their long-term counterparts, confirming a positive trend. Even the 3-month MACD indicator is currently flashing a buy signal. Critical technical support is identified at €374.70, with resistance waiting at €406.70.
Confident Outlook Driven by Innovation
Looking ahead, CEO Nicolas Hieronimus expressed confidence that L’Oréal is well-positioned to continue outperforming the global beauty market and further enhance its profitability throughout the remainder of the year. The company is forecasting an acceleration in market growth during the second half of 2025, fueled by new product launches and sustained investment in its “Beauty Tech Company” strategic initiative. This strategy involves significant capital allocation towards artificial intelligence and digital innovation to develop personalized beauty experiences. Management also confirmed it is making preparations for the potential financial impact of new tax policies in several of its key operational markets.
Ad
L'Oréal Stock: Buy or Sell?! New L'Oréal Analysis from August 29 delivers the answer:
The latest L'Oréal figures speak for themselves: Urgent action needed for L'Oréal investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 29.
L'Oréal: Buy or sell? Read more here...